Drug profile · INN
regorafenib
STIVARGA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
regorafenib (STIVARGA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN regorafenib
Brand STIVARGA
Route ORAL
Formulation TABLET
ATC code L01EX05
Frequently asked questions
What is regorafenib?
regorafenib (STIVARGA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for regorafenib?
STIVARGA is a marketed brand name for regorafenib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of regorafenib?
regorafenib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.